chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a nurse, via a company representative, refers to a female patient of unknown age. In 2013 (reported as "sometime last year") the patient was vaccinated with ZOSTAVAX, subcutaneous for prevention of herpes zoster. Dosing information and lot number were not provided. On an unknown date the patient was seen in the office and had a very red and swollen arm but there were no pustules or rash. The outcome of the event and the causality assessment were not provided. Additional information has been requested.
Injection site reaction about 24 hrs after administration which grew very large (red, swollen, itchy). On 9/1/12 pt noticed a rash developing on her (L) side of abdomen. Rash continued to spread & is located from neck to buttocks. A patch on her neck is very red & swollen (pt noticed this on 9/7). Pt reports rash is somewhat itchy but not painful.
Patient given immunization 10/05/11. Had Rx that evening (L) arm - swelling, redness, heat, no fever.
My son got his first dose of the Pfizer vaccine for COVID-19 on 6/24/2022. He had pain at the site of the injection for 48 hours. Afterwards, he became intermittently feverish. He reached a fever of 102.3  on 6/28/2022 at 3:30 PM. We gave him Tylenol and called the pediatrician's office. The fever then went away. The pediatrician advised us to monitor his condition and told us to bring him to her office if his situation did not improve; she suspected that the fever was connected to the vaccine. Thankfully, there has not been a recurrence of the fever ever since, and there no longer appears to be pain at the injection site.
COVID-19  I received my 2nd booster shot on 04/01/2022 and my COVID-19 symptoms started on 06/27/2022. I tested positive on the 06/30/2022. I had cough, body aches, runny nose, tightness in my chest. I had a appointment  for asthma he gave me medication for it since i tested negative for COVID. I tested positive on 06/30/2022 and i called my doctor again he prescribed  PAXLOVID for 5 days.  I still have cough. and i still tested positive till today 07/05/2022.
Pfizer #2 was given on 1/23/23 and bivalent given too soon on 2/14/23.
Her left hand is still swollen/Her right foot is also swollen now so she's not walking much/ if she goes 100 or 200 steps then it gets so swollen like a bulge; not walking much; over time it has gotten hard and it feels like a big rock; She is in so much pain that she can't sleep at night or put any weight on her left hand; She is in so much pain that she can't sleep at night or put any weight on her left hand; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Her left hand is still swollen/Her right foot is also swollen now so she's not walking much/ if she goes 100 or 200 steps then it gets so swollen like a bulge), GAIT DISTURBANCE (not walking much), INDURATION (over time it has gotten hard and it feels like a big rock), PAIN IN EXTREMITY (She is in so much pain that she can't sleep at night or put any weight on her left hand) and INSOMNIA (She is in so much pain that she can't sleep at night or put any weight on her left hand) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Her left hand is still swollen/Her right foot is also swollen now so she's not walking much/ if she goes 100 or 200 steps then it gets so swollen like a bulge), GAIT DISTURBANCE (not walking much), INDURATION (over time it has gotten hard and it feels like a big rock), PAIN IN EXTREMITY (She is in so much pain that she can't sleep at night or put any weight on her left hand) and INSOMNIA (She is in so much pain that she can't sleep at night or put any weight on her left hand). At the time of the report, PERIPHERAL SWELLING (Her left hand is still swollen/Her right foot is also swollen now so she's not walking much/ if she goes 100 or 200 steps then it gets so swollen like a bulge), GAIT DISTURBANCE (not walking much), INDURATION (over time it has gotten hard and it feels like a big rock), PAIN IN EXTREMITY (She is in so much pain that she can't sleep at night or put any weight on her left hand) and INSOMNIA (She is in so much pain that she can't sleep at night or put any weight on her left hand) outcome was unknown.            No Concomitant medications were provided. No Treatment medications were provided.
Pt was administered a booster dose at this time on 12/18/21 and was discovered after the injection they were not 16 years old. They are 15 years and 4 months.
Information has been received from a physician via Company representative concerning to a patient of unknown age and gender. Concurrent and historical conditions were not reported. Concomitant therapies were not provided. On 15-MAY-2015, the patient was vaccinated with an improperly stored dose of GARDASIL "10x1 sdv" (Lot No. K001631, exp. 06-NOV-2016) (dose and site not reported). The vaccine was in excursion with a sum of hours of 48. The lowest recorded temperatures were of 32 respectively. The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Approximately two weeks after the first does, I started to experience itchiness and puffiness of the skin around my left eye.  The condition still exists today and I'm starting to notice it happening around my right eye.  The skin will become dry and eventually flake if I do not put Vaseline on it.  I did mention this condition to my medical provider during my routine physical and he thinks it is allergy related.  He said to sparingly put a Cortisone cream on it, which seems to help.    The day after the second dose, I experienced body aches.
Information has been received from a pharmacist concerning a male patient with an active case of shingles who on an unspecified date ("a few weeks ago"), was vaccinated with a dose of ZOSTAVAX (Merck) (lot# not reported). Subsequently, the patient had a worsening of symptoms. Unspecified medical attention was sought. The patient's shingles persisted. Additional information has been requested.
This spontaneous report was received from a pharmacist refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 22-MAY-2023, the patient was vaccinated with the dose of improper storage PROQUAD lot #W029552, expiration date: 14-MAR-2024 (exact dose, route of administration and anatomical location were not reported) for prophylaxis instead of M-M-R II (wrong product administered). Administered dose of vaccine was exposed to the temperature excursion of 8 degrees Celsius for 1440 hours (improper storage of product in use). No previous temperature excursion had occurred. There were no additional adverse events reported (no adverse event).
This spontaneous report was received from a medical assistant referring to multiple unspecified patients of unknown age and gender. The patient's pertinent medical history, concurrent conditions or concomitant medications were not reported. On 09-MAY-2017, 10-MAY-2017, and 12-MAY-2017, unspecified patients were vaccinated with improperly stored doses of PNEUMOVAX 23 (lot # N005597, expiration date: 19-OCT-2017) (dose, frequency and route of administration were unspecified) for prophylaxis. Additionally, it was reported that on 22-MAY-2017, 24-MAY-2017, and 25-MAY-2017, unspecified patients were also vaccinated with improperly stored doses of PNEUMOVAX 23 (lot # N010105, expiration date: 15-NOV-2017) (dose, frequency and route of administration were unspecified) for prophylaxis. No adverse effects or product quality complaints were reported. It was reported that all vaccines were exposed to a temperature between 48-50 Fahrenheit degrees, from 04-MAY-2017 until 25-MAY-2017 (21 days), that digital data logger was not involved, and that there were no previous excursions. Additional information has been requested.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), HEADACHE (Mild headache) and PYREXIA (Slight fever) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. Concurrent medical conditions included Hypertension since April 2019, Cholesterol since April 2019, Allergy to antibiotic (cipro), Food allergy (some food allergy), Drug allergy (statins) and Allergy (fiber glass). Concomitant products included EVOLOCUMAB (REPATHA) for Cholesterol, CARVEDILOL from April 2019 to an unknown date, LISINOPRIL, CLOPIDOGREL and ASPIRIN [ACETYLSALICYLIC ACID] for Hypertension, MINERALS NOS, VITAMINS NOS (ONE A DAY [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), HEADACHE (Mild headache) and PYREXIA (Slight fever). At the time of the report, PAIN IN EXTREMITY (Sore arm), HEADACHE (Mild headache) and PYREXIA (Slight fever) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No treatment medications were reported. This case was linked to MOD-2021-076430. Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Follow-up received does not contain any new information with respect to dose 1.
Had reaction 48 hours after receiving the second dose of Moderna. Threw up over 100 times between 1:50 PM till 5:30 PM, It all ended with diarrhea. Experienced chills and shivering. No fever. Body ache throughout the body, especially pelvic region. Experienced fatigue the next day. Recovered by resting.
Initial report received from a consumer on 18 October 2010. A 77-year-old female patient, with a medical history of GERD and thyroid disease, received on 21 September 2010 a left deltoid intramuscular (IM) injection of INFLUENZA VACCINE, lot number not reported. Her concomitant medications included LIPITOR, SYNTHROID AND PREVACID. The patient had no illness at the time of vaccination and no other vaccinations within 4 weeks prior to the FLUZONE. The patient had soreness of the left deltoid and the whole arm for 3-4 days after vaccination. The patient now has tingling of the arm from the deltoid to the fingers. The sensation comes and goes and she feels as if her arm was falling asleep. The outcome was reported as not recovered. Follow-up information was received from a health care professional on 06 December 2010. The patient received on 21 September 2010 at 4:15 PM FLUZONE, lot number U3565AA. The patient had intravenous (IV) dye and many test done since vaccination. The patient stated that anxiety makes the tingling worse. The patient has not been seen by a physician specifically for this reaction nor has she required treatment. The patient still has some tingling. The outcome remained not recovered. Follow-up information received was received from a health care professional on 27 January 2011 reported that the patient had a left breast lumpectomy in December. The patient's soreness and tingling experienced after injection has gone away. She still has different tingling across the back and shoulder, "like champagne bubbles", occasionally but all the pain has gone away. The outcome remained not recovered. Follow-up information was received from a health care professional on 23 February 2011 reported that there was no additional information to add at this time. The outcome remained not recovered. Follow-up information was received from a health care professional on 21 March 2011, who reported that there was no additional information to add at this time. The outcome remained not recovered. Follow-up information was received from a health care professional on 04 August 2011. The patient reported that her arm problems persisted for approximately one month after vaccination. The patient's outcome was reported as fully recovered. Documents held by sender: None.
Pt states ..."shingles vaccine has caused me to loose hearing."  Pt went to see ENT and saw NP.
8 days after vaccination developed a large circular hot itchy red sore welt at injection site. As of today only slight redness and soreness remain.
I had the vaccine and about 12 hours later I woke up with shacking chills, fatigue, body aches and runny nose. About 10 days after I was cleaning the kitchen and I was feeling okay but that night I woke up with shortness of breath and I had an asthma attack, I called my primary doctor and she said if I was not getting better to go to the ER. She told me to do 3 nebulizers over an hour and I felt better and she ordered prednisone and my husband picked it the next day.
patient developed swelling  to face, and reported itchiness to throat that resolved quickly, facility gave her Benadryl and she responded well to that
fainting approximately 5 seconds and hyptotension 85/41 cold packs rest 30 minutes
110 heartbeat per minute; Fogginess; Nausea; Mild pain at injection site; Headache; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (110 heartbeat per minute), FEELING ABNORMAL (Fogginess), NAUSEA (Nausea), VACCINATION SITE PAIN (Mild pain at injection site) and HEADACHE (Headache) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced HEART RATE INCREASED (110 heartbeat per minute), FEELING ABNORMAL (Fogginess), NAUSEA (Nausea), VACCINATION SITE PAIN (Mild pain at injection site), HEADACHE (Headache) and PYREXIA (Fever). At the time of the report, HEART RATE INCREASED (110 heartbeat per minute), FEELING ABNORMAL (Fogginess), NAUSEA (Nausea), VACCINATION SITE PAIN (Mild pain at injection site), HEADACHE (Headache) and PYREXIA (Fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included:Beta Blocker meds,Blood pressure meds Thyroid meds   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: outcome reported and denied further follow up
reaction to the nitrofurantoin mono-mcr; brain fog (which came and went); weight loss (lost 20 lbs); very little energy; bleeding from the bladder/bleeding from his bladder lasted for a couple of weeks sporadically/ passed a blood clot; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URINARY BLADDER HAEMORRHAGE (bleeding from the bladder/bleeding from his bladder lasted for a couple of weeks sporadically/ passed a blood clot) in an 86-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A and 021B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Gluten intolerance and Allergy to antibiotic (nitrofurantoin mono-mcr).   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 14-May-2021, the patient experienced FEELING ABNORMAL (brain fog (which came and went)), WEIGHT DECREASED (weight loss (lost 20 lbs)) and ASTHENIA (very little energy). In May 2021, the patient experienced URINARY BLADDER HAEMORRHAGE (bleeding from the bladder/bleeding from his bladder lasted for a couple of weeks sporadically/ passed a blood clot) (seriousness criterion medically significant). On an unknown date, the patient experienced ADVERSE DRUG REACTION (reaction to the nitrofurantoin mono-mcr). The patient was treated with ACETAMINOPHEN at a dose of UNK dosage form and NITROFURANTOIN at a dose of 100 mg, 1 dose. In June 2021, URINARY BLADDER HAEMORRHAGE (bleeding from the bladder/bleeding from his bladder lasted for a couple of weeks sporadically/ passed a blood clot) had resolved. At the time of the report, FEELING ABNORMAL (brain fog (which came and went)), WEIGHT DECREASED (weight loss (lost 20 lbs)), ASTHENIA (very little energy) and ADVERSE DRUG REACTION (reaction to the nitrofurantoin mono-mcr) outcome was unknown.            No relevant concomitant medications were provided. Patient  experienced the events within a week after receiving the second dose of the vaccine. Patient had visited the emergency room (ER) multiple times for the bleeding from the bladder and  tests were done.  It is stated that within a week, the patient experienced bleeding from the bladder, brain fog (which came and went), weight loss, which started shortly after second shot (lost 20 lbs), from start had very little energy (which was sporadic but had improved). This was not on 14-MAY-2021.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.   This case was linked to MOD-2021-220964 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested.
104F temperature in 12 hours post vaccination.  Body aches. Chills, severe malaise
p/ pt recv vax approx 15 mo later devel otitis media. treated w/ceclor. then 2 days p/ that pt devel chickenpox w/vesicular lesions
Have ringing in my ears, which never had before.; Dizziness; Foggy head; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 23Mar2021 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02Mar2021 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced ringing in ears which the patient never had before, dizziness and a foggy head. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. On an unknown date in Mar2021, the patient underwent nasal swab and the result was unknown. The clinical outcome of the events ringing in ears, dizziness and foggy head was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Pt c/o flushing/sweating and lightheaded/dizziness immediately after vaccination.  H/o lightheadedness with flu vaccine in the past. Pt ate rice and eggs at 2pm today, no breakfast. Pt's symptoms resolved after drinking 500mL apple juice and laying down with knees bent. Advised taking 2nd dose supine.  BP 109/69, HR 63, RR 18 -- > 108/68, 64, 16 -- > 112/79, 75, 16.  Pt stable and released from the vaccination site.
Information has been received from a registered nurse referring to unspecified numbers of patients of unknown age. There was no information about the patients' medical history and concurrent condition. On unknown dates the patients were vaccinated with improperly stored GARDASIL (lot # K001500, expiration date: 05-MAY-2017; lot # K008213, expiration date: 17-DEC-2016; lot # K001500, expiration date: 06-NOV-2016) (strength, dose and route unknown). There was no information about concomitant therapy. No adverse effects were reported. This is one of the reports received from the same reporter. Additional information has been requested.
Onset of multiple seizure-like episodes 04/01/02 consisting of about 2-3 min tonic clonic generalized, eyes deviating upward, irregular breathing. Felt by neurologist compatible with sz disorder. EEG normal, development normal. No anti-convulsants yet prescribed.
Patient tested positive for COVID-19.  Symptoms include sinus congestion, partial anosmia, partial ageusia
PATIENT CALLED COMPLAINED OF SORENESS IN RIGHT ARM.  SHE COMPLAINED THAT IS MORE SORE WITH MOVEMENT.  PATIENT THINKS THAT A NERVE WAS POSSIBLY HIT
2 hours after vaccine, patient felt dizzy, tremulous, short of breath, fever to 102 degrees, had night sweats, emesis twice, headache.
Site: Redness at Injection Site-Mild, Systemic: Abdominal Pain-Severe, Systemic: Body Aches Generalized-Severe, Systemic: Chills-Severe, Systemic: Dizziness / Lightheadness-Severe, Systemic: Exhaustion / Lethargy-Severe, Systemic: Fever-Severe, Systemic: Flushed / Sweating-Severe, Systemic: Nausea-Severe, Systemic: Shakiness-Severe, Systemic: Tachycardia-Medium, Systemic: Vomiting-Severe, Systemic: Weakness-Severe, Additional Details: extreme vertigo
This spontaneous report as received from a healthcare worker refers to 110 patients of unknown age and gender. On an unknown date the patients were vaccinated with GARDASIL, 0.5 ml, via intramuscular, (lot and expiration date were not reported), the doses that had been exposed to light, as far back as September 2012, there was no concomitant medications reported. It was noted that the vaccines were stored at the front of a glass door refrigerator, outside of their boxes, in a room with fluorescent light that is on 24 hours a day. No adverse effect reported. Additional information has been requested.
Numbness in fingers and toes of both hands and feet. Patient contacted provider and was told this is known to occur and to alternate Tylenol and Advil. Patient noticed on day 3 after second dose of vaccine around 8 am, talked with patient at 6 pm and he states the numbness is still there but to a much lesser degree